HyperFoods: Machine intelligent mapping of cancer-beating molecules in foods.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
03 07 2019
Historique:
received: 21 03 2019
accepted: 03 06 2019
entrez: 5 7 2019
pubmed: 5 7 2019
medline: 21 10 2020
Statut: epublish

Résumé

Recent data indicate that up-to 30-40% of cancers can be prevented by dietary and lifestyle measures alone. Herein, we introduce a unique network-based machine learning platform to identify putative food-based cancer-beating molecules. These have been identified through their molecular biological network commonality with clinically approved anti-cancer therapies. A machine-learning algorithm of random walks on graphs (operating within the supercomputing DreamLab platform) was used to simulate drug actions on human interactome networks to obtain genome-wide activity profiles of 1962 approved drugs (199 of which were classified as "anti-cancer" with their primary indications). A supervised approach was employed to predict cancer-beating molecules using these 'learned' interactome activity profiles. The validated model performance predicted anti-cancer therapeutics with classification accuracy of 84-90%. A comprehensive database of 7962 bioactive molecules within foods was fed into the model, which predicted 110 cancer-beating molecules (defined by anti-cancer drug likeness threshold of >70%) with expected capacity comparable to clinically approved anti-cancer drugs from a variety of chemical classes including flavonoids, terpenoids, and polyphenols. This in turn was used to construct a 'food map' with anti-cancer potential of each ingredient defined by the number of cancer-beating molecules found therein. Our analysis underpins the design of next-generation cancer preventative and therapeutic nutrition strategies.

Identifiants

pubmed: 31270435
doi: 10.1038/s41598-019-45349-y
pii: 10.1038/s41598-019-45349-y
pmc: PMC6610092
doi:

Substances chimiques

Antineoplastic Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

9237

Références

Front Genet. 2013 Dec 04;4:270
pubmed: 24363662
Front Physiol. 2017 Sep 28;8:753
pubmed: 29033850
Nature. 2000 Jun 22;405(6789):903-4
pubmed: 10879522
Adv Nutr. 2014 May 14;5(3):306S-11S
pubmed: 24829482
Nature. 2014 Nov 27;515(7528):518-22
pubmed: 25383533
Nutr Rev. 1997 Feb;55(2):31-43
pubmed: 9155216
PLoS Comput Biol. 2010 Jan 15;6(1):e1000641
pubmed: 20090828
Nat Commun. 2017 Sep 18;8(1):573
pubmed: 28924171
Chem Biol Interact. 2010 Nov 5;188(2):276-88
pubmed: 20430016
Nat Genet. 2019 Jan;51(1):12-18
pubmed: 30478442
Nat Methods. 2013 Nov;10(11):1108-15
pubmed: 24037242
Bioinformatics. 2018 Jul 15;34(14):2474-2482
pubmed: 29538614
Nucleic Acids Res. 2019 Jan 8;47(D1):D941-D947
pubmed: 30371878
J Nat Prod. 2016 Mar 25;79(3):629-61
pubmed: 26852623
Nucleic Acids Res. 2018 Jan 4;46(D1):D1210-D1216
pubmed: 29059383
Curr Med Chem. 2019;26(19):3567-3583
pubmed: 28462705
Nat Rev Genet. 2011 Jan;12(1):56-68
pubmed: 21164525
J Agric Food Chem. 2011 May 11;59(9):4331-48
pubmed: 21438636
Chem Res Toxicol. 2016 Dec 19;29(12):2071-2095
pubmed: 27989132
Cell. 2015 Jul 16;162(2):425-440
pubmed: 26186194
Biochemistry. 2005 Jun 7;44(22):8167-75
pubmed: 15924436
Am J Clin Nutr. 2014 Jun;99(6):1286-308
pubmed: 24760973
Nucleic Acids Res. 2015 Jan;43(Database issue):D36-42
pubmed: 25355515
Nat Rev Drug Discov. 2019 Jan;18(1):41-58
pubmed: 30310233
Medicine (Baltimore). 2017 Mar;96(13):e6426
pubmed: 28353571
Nucleic Acids Res. 2019 Jan 8;47(D1):D506-D515
pubmed: 30395287
Nucleic Acids Res. 2010 Jan;38(Database issue):D781-6
pubmed: 19897546
Nucleic Acids Res. 2019 Jan 8;47(D1):D963-D970
pubmed: 30371892
Sci Data. 2017 Mar 14;4:170029
pubmed: 28291243
Lancet. 2014 Jun 7;383(9933):1947-8
pubmed: 24910221
Pharmacol Ther. 2013 May;138(2):255-71
pubmed: 23356980
Nutrients. 2018 Dec 03;10(12):
pubmed: 30513889
Nucleic Acids Res. 2010 Jan;38(Database issue):D552-6
pubmed: 19897548
J Nutr. 2004 Dec;134(12 Suppl):3479S-3485S
pubmed: 15570057
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Oncotarget. 2016 Aug 9;7(32):52517-52529
pubmed: 27232756
Front Pharmacol. 2017 Jun 30;8:420
pubmed: 28713272
Curr Med Chem. 2016;23(6):520-77
pubmed: 26695512
Nucleic Acids Res. 2019 Jan 8;47(D1):D607-D613
pubmed: 30476243
Nutr J. 2004 Oct 20;3:19
pubmed: 15496224
Nucleic Acids Res. 2015 Jan;43(Database issue):D940-5
pubmed: 25106869
Cancer Cell Int. 2014 Feb 28;14(1):18
pubmed: 24576043
Database (Oxford). 2017 Jan 1;2017:
pubmed: 29220436
Nucleic Acids Res. 2017 Jan 4;45(D1):D932-D939
pubmed: 27789690
Front Genet. 2015 Apr 23;6:157
pubmed: 25954303
Cancer Lett. 2011 Dec 15;312(1):11-7
pubmed: 21899946
Lancet Oncol. 2016 Apr;17(4):407-409
pubmed: 26947330
Nat Biotechnol. 2007 Oct;25(10):1119-26
pubmed: 17921997
Proc Natl Acad Sci U S A. 2014 Jan 21;111(3):1216-21
pubmed: 24398526
Lancet. 2015 Feb 7;385(9967):549-62
pubmed: 25468153
Cancer Res. 2005 Apr 15;65(8):3389-95
pubmed: 15833873
Nucleic Acids Res. 2018 Jan 4;46(D1):D1074-D1082
pubmed: 29126136
Nutr Cancer. 2018 Apr;70(3):404-412
pubmed: 29578816
Proc Natl Acad Sci U S A. 2007 May 22;104(21):8685-90
pubmed: 17502601
Int J Biol Sci. 2018 Jul 13;14(10):1232-1244
pubmed: 30123072
Nutr Rev. 2013 Sep;71(9):585-99
pubmed: 24032363
NPJ Precis Oncol. 2017 Aug 8;1(1):25
pubmed: 29872707
Maturitas. 2016 Dec;94:13-19
pubmed: 27823732
Crit Rev Food Sci Nutr. 2017 Nov 2;57(16):3449-3463
pubmed: 26853447

Auteurs

Kirill Veselkov (K)

Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, SW7 2AZ, UK. kirill.veselkov04@imperial.ac.uk.

Guadalupe Gonzalez (G)

Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, SW7 2AZ, UK.
Department of Computing, Faculty of Engineering, Imperial College London, London, SW7 2AZ, UK.

Shahad Aljifri (S)

Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, SW7 2AZ, UK.

Dieter Galea (D)

Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, SW7 2AZ, UK.

Reza Mirnezami (R)

Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, SW7 2AZ, UK.

Jozef Youssef (J)

Kitchen Theory, London, EN5 4LG, UK.

Michael Bronstein (M)

Department of Computing, Faculty of Engineering, Imperial College London, London, SW7 2AZ, UK.

Ivan Laponogov (I)

Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, SW7 2AZ, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH